Considering the tendency of tumor cells to reduce the expression of MHC I, thereby evading the killing effect of cytotoxic T lymphocytes (CTLs), the traditional killing of tumors by CD8+T cells often fails to achieve the expected outcome [23,43,44]. This evidence concerns the gene CD8A and neoplasm.